Ostarine

Routes
Oral (PO)
Half-Life (t½)
PO: 24h
Formula
C19H14F3N3O3
Molecular Weight
389.33 g/mol
PubChem CID
11326715
Aliases
MK-2866, GTx-024, Enobosarm

Pharmacological Mechanism

First-generation non-steroidal SARM. Gentle AR activation producing muscle anabolism + bone density with minimal prostate / virilising effects. The most-studied SARM in human trials (POWER trials in NSCLC + breast cancer cachexia).

Half-Life & Elimination Curve (PO: 24h)

100%50%25%12.5%0%0h0×t½24h1×t½48h2×t½3d3×t½4d4×t½5d5×t½0×t½ (0h): 100% remaining1×t½ (24h): 50% remaining2×t½ (48h): 25% remaining3×t½ (3d): 12.5% remaining4×t½ (4d): 6.3% remaining5×t½ (5d): 3.1% remaining
Elimination (PO)
  • 0×t½0h100%
  • 1×t½24h50%
  • 2×t½48h25%
  • 3×t½3d12.5%
  • 4×t½4d6.3%
  • 5×t½5d3.1%
Elimination t½24h (PO)
Rate Constant (ke)0.0289 h⁻¹
97% Washout (5×t½)5d

Dosing Guidelines

Pathways It Modulates

Target Organ Systems

Chemical Structure & Identifiers

References